115 related articles for article (PubMed ID: 16301805)
41. GENOTYPE AND DRUG RESISTANCE OF CLINICAL AND ENVIRONMENTAL VIBRIO CHOLERAE NON-O1/NON-O139 IN NORTHEASTERN THAILAND.
Chomvarin C; Jumroenjit W; Tangkanakul W; Hasan NA; Chaicumpar K; Faksri K; Huq A
Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1354-64. PubMed ID: 26466421
[TBL] [Abstract][Full Text] [Related]
42. Characterization of potentially virulent non-O1/non-O139 Vibrio cholerae strains isolated from human patients.
Cariri FA; Costa AP; Melo CC; Theophilo GN; Hofer E; de Melo Neto OP; Leal NC
Clin Microbiol Infect; 2010 Jan; 16(1):62-7. PubMed ID: 19456828
[TBL] [Abstract][Full Text] [Related]
43. Gene cloning and properties of the RND-type multidrug efflux pumps MexPQ-OpmE and MexMN-OprM from Pseudomonas aeruginosa.
Mima T; Sekiya H; Mizushima T; Kuroda T; Tsuchiya T
Microbiol Immunol; 2005; 49(11):999-1002. PubMed ID: 16301811
[TBL] [Abstract][Full Text] [Related]
44. Functional cloning and expression of emeA, and characterization of EmeA, a multidrug efflux pump from Enterococcus faecalis.
Lee EW; Chen J; Huda MN; Kuroda T; Mizushima T; Tsuchiya T
Biol Pharm Bull; 2003 Feb; 26(2):266-70. PubMed ID: 12576692
[TBL] [Abstract][Full Text] [Related]
45. [Development of both multiple PCR and real-time SYBR green PCR for the detection of Vibrio cholerae non-O1/O139 serogroups].
Li F; Kan B; Wang D
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jan; 35(1):66-70. PubMed ID: 24685041
[TBL] [Abstract][Full Text] [Related]
46. ATP-Binding Cassette Transporter VcaM from Vibrio cholerae is Dependent on the Outer Membrane Factor Family for Its Function.
Lu WJ; Lin HJ; Janganan TK; Li CY; Chin WC; Bavro VN; Lin HV
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584668
[No Abstract] [Full Text] [Related]
47. AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters.
Su XZ; Chen J; Mizushima T; Kuroda T; Tsuchiya T
Antimicrob Agents Chemother; 2005 Oct; 49(10):4362-4. PubMed ID: 16189122
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of virulence genes (ctxA, stn, OmpW and tcpA) among non-O1 Vibrio cholerae isolated from fresh water environment.
Sharma A; Chaturvedi AN
Int J Hyg Environ Health; 2006 Nov; 209(6):521-6. PubMed ID: 16891156
[TBL] [Abstract][Full Text] [Related]
49. Isolation of New Delhi metallo-β-lactamase 1-producing Vibrio cholerae non-O1, non-O139 strain carrying ctxA, st and hly genes in southern Vietnam.
Diep TT; Nguyen NT; Nguyen TN; An HK; Nguyen TQ; Nguyen VH; Nguyen TV; Nguyen TN; Izumiya H; Ohnishi M; Yamashiro T; Nguyen LT
Microbiol Immunol; 2015 May; 59(5):262-7. PubMed ID: 25683557
[TBL] [Abstract][Full Text] [Related]
50. VopF, a type III effector protein from a non-O1, non-O139 Vibrio cholerae strain, demonstrates toxicity in a Saccharomyces cerevisiae model.
Tripathi R; Singh Naorem S; Dureja C; Haldar S; Mondal AK; Raychaudhuri S
J Med Microbiol; 2010 Jan; 59(Pt 1):17-24. PubMed ID: 19779031
[TBL] [Abstract][Full Text] [Related]
51. Virulence factors of non-O1 non-O139 Vibrio cholerae isolated in Córdoba, Argentina.
Bidinost C; Saka HA; Aliendro O; Sola C; Panzetta-Duttari G; Carranza P; Echenique J; Patrito E; Bocco JL
Rev Argent Microbiol; 2004; 36(4):158-63. PubMed ID: 15786867
[TBL] [Abstract][Full Text] [Related]
52. [Antibiotic Susceptibility of Vibrio cholerae non O1/non O139 Serogroups Isolated from Environment in the Rostov Region].
Selyanskaya NA; Trishina AV; Verkina LM; Arkhangelskaya IV; Kruglikov VD; Zlenko YM
Antibiot Khimioter; 2014; 59(11-12):16-9. PubMed ID: 26448988
[TBL] [Abstract][Full Text] [Related]
53. Characterization of two novel gene cassettes, dfrA27 and aadA16, in a non-O1, non-O139 Vibrio cholerae isolate from China.
Sun J; Zhou M; Wu Q; Ni Y
Clin Microbiol Infect; 2010 Aug; 16(8):1125-9. PubMed ID: 19906273
[TBL] [Abstract][Full Text] [Related]
54. ROLE OF HLYA-POSITIVE VIBRIO CHOLERAE NON-O1/NON-O139 ON APOPTOSIS AND CYTOTOXICITY IN A CHINESE HAMSTER OVARY CELL LINE.
Kanoktippornchai B; Chomvarin C; Hahnvajanawong C; Nutrawong T
Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1365-75. PubMed ID: 26466422
[TBL] [Abstract][Full Text] [Related]
55. Investigating the virulence genes and antibiotic susceptibility patterns of Vibrio cholerae O1 in environmental and clinical isolates in Accra, Ghana.
Abana D; Gyamfi E; Dogbe M; Opoku G; Opare D; Boateng G; Mosi L
BMC Infect Dis; 2019 Jan; 19(1):76. PubMed ID: 30665342
[TBL] [Abstract][Full Text] [Related]
56. A genomic island in Vibrio cholerae with VPI-1 site-specific recombination characteristics contains CRISPR-Cas and type VI secretion modules.
Labbate M; Orata FD; Petty NK; Jayatilleke ND; King WL; Kirchberger PC; Allen C; Mann G; Mutreja A; Thomson NR; Boucher Y; Charles IG
Sci Rep; 2016 Nov; 6():36891. PubMed ID: 27845364
[TBL] [Abstract][Full Text] [Related]
57. Characterization of putative multidrug resistance transporters of the major facilitator-superfamily expressed in Salmonella Typhi.
Shaheen A; Ismat F; Iqbal M; Haque A; De Zorzi R; Mirza O; Walz T; Rahman M
J Infect Chemother; 2015 May; 21(5):357-62. PubMed ID: 25724589
[TBL] [Abstract][Full Text] [Related]
58. Gene cloning and characterization of EfmA, a multidrug efflux pump, from Enterococcus faecium.
Nishioka T; Ogawa W; Kuroda T; Katsu T; Tsuchiya T
Biol Pharm Bull; 2009 Mar; 32(3):483-8. PubMed ID: 19252300
[TBL] [Abstract][Full Text] [Related]
59. In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139.
Su BA; Tang HJ; Wang YY; Liu YC; Ko WC; Liu CY; Chuang YC;
J Microbiol Immunol Infect; 2005 Dec; 38(6):425-9. PubMed ID: 16341343
[TBL] [Abstract][Full Text] [Related]
60. Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae.
Colmer JA; Fralick JA; Hamood AN
Mol Microbiol; 1998 Jan; 27(1):63-72. PubMed ID: 9466256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
